Pharmacology

Action Mechanism of Action Reference
AGONIST Tumor necrosis factor receptor superfamily member 4 agonist

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Triple Negative Breast Neoplasms 2 D064726 ClinicalTrials
Carcinoma, Renal Cell 2 D002292 ClinicalTrials
Carcinoma, Renal Cell 2 D002292 ClinicalTrials
Prostatic Neoplasms 1 D011471 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Lymphoma, Follicular 1 D008224 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Leukemia, Myeloid, Acute 1 D015470 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297883
FDA SRS APS3IS9D6W